LivaNova stock trades at EUR 70.00 ahead of November 4 results

Published on 10/20/2026 at 13:54 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

LivaNova lifted 2026 growth guidance to 8%-9% after second-quarter revenue rose 10.80 percent. LivaNova stock costs EUR 70.00 on October 20, 2026.

Reporting date and growth guidance

LivaNova lifted 2026 revenue growth guidance to 8%-9% on August 5, 2026.
Second-quarter revenue reached USD 390.59 million, up 10.80 percent year over year.
LivaNova stock trades at EUR 70.00 at 1:45 p.m. CEST at Lang & Schwarz on October 20, 2026.
Third-quarter results are scheduled for November 4, 2026.

LIVN, GB00BYMT0J19, Illustration mit AI erstellt.

LivaNova (ISIN GB00BYMT0J19) was trading at EUR 70.00 at Lang & Schwarz on October 20, 2026, at 1:45 p.m. CEST. The next scheduled report is the company's third-quarter update on November 4, 2026, according to LivaNova.

November 4 is the next test

The upcoming report will show whether the higher full-year outlook remains supported by demand in LivaNova's Cardiopulmonary and Neuromodulation businesses. The investor-relations calendar states that third-quarter results will be released before a conference call on November 4, 2026, at 1:00 p.m. Greenwich Mean Time and 8:00 a.m. Eastern Time, as reported by Business Wire.

What does guidance mean for growth?

The second-quarter figures provide the operating benchmark. LivaNova reported revenue of USD 390.59 million for the second quarter of 2026, up 10.80 percent from the prior-year period, while adjusted earnings per share reached USD 1.26 against a USD 1.09 consensus estimate, according to MarketBeat. On August 5, 2026, the company raised full-year 2026 revenue growth guidance to 8%-9%, making revenue conversion and cash generation the central questions for the next report.

Three dates shape the story

The recent sequence began on August 5, 2026, when LivaNova reported second-quarter revenue of USD 390.59 million. On September 23, 2026, the company announced the November 4 results date. On October 8, 2026, Barclays upgraded LivaNova to Strong Buy and set a USD 105.00 price target, as reported by MarketBeat.

Stock sits below its yearly high

The primary Nasdaq listing last stood at USD 78.14 on October 19, 2026, at 4:00 p.m. ET. Its 52-week range was USD 48.82 to USD 85.76, leaving the company valued at USD 4.3 billion on that date. The euro quotation puts the German investor's attention on the November report, while the latest guidance and analyst view set a demanding comparison for execution.

LivaNova was trading at EUR 70.00 at Lang & Schwarz on October 20, 2026, at 1:45 p.m. CEST.

The further course of trading is shown by the continuously updated real-time quote of LivaNova stock.